Clinical Trial Update: Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma [Phase 2]

View source ↗

Summary

Phase 2 study assessing the bronchodilatory effect of a single dose QMF149 (indacaterol maleate/mometasone furoate) delivered via Twisthaler in adults with asth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QMF149 (mometasone/formoterol)

Snippet

Sponsor: Novartis | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-04-22